ALIM - Alimera Science Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 CCL (-0.79%) CLR (2.28%) AAL (1.13%) CUK (1.07%) FCX (2.36%) KSS (3.53%) LUV (-0.5%) PBCT (2.37%) CZR (0.65%) DAL (0.86%) CNHI (1.52%) BPMC (1.93%) FTI (0.92%) HTHT (-0.95%) MRO (1.09%) PACW (4.61%) PLTR (3.54%) RCL (-2.46%) BCO (3.74%) AL (0.83%) CPRI (3.73%) EWBC (3.41%) GTT (-2.4%) H (0.57%) JBT (2.23%)

Up 5% to $8.54 today

ALIM - Alimera Sciences

$8.38 0.31[3.85%]

15 mins delayed data

People also watch : AERI | MATN | REGN | INSM

+Watchlist

Analyst Ratings | Earnings

Previous Close	$8.07	Open	$7.99
Volume	32.2K	Market Cap	63.9M
Yield		Last Dividend

Day

52 Week

The Daily Biotech Pulse: DermTech Soars ...	02/11/21
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X...

The Daily Biotech Pulse: Fluidigm's Sali...	01/22/21
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) Aca...

Alimera Sciences to Present at the H.C. ...	01/05/21
ATLANTA, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development of???

Alimera Sciences Announces Third Quarter...	10/28/20
Rebound Continues from COVID Challenges

Alimera Sciences to Report Third Quarter...	10/22/20
Conference Call to be held Thursday, October 29, 2020 at 9:00am Eastern Time

Alimera Sciences to Report Second Quarte...	07/22/20
Conference Call to be held Thursday, July 30, 2020 at 9:00 AM Eastern Time

Alimera Sciences (ALIM) Reports Q1 Loss,...	04/29/20
Alimera Sciences (ALIM) delivered earnings and revenue surprises of 44.19% and 3.53%, respectively, for the quarter ended March 2020. Do the numbers h...

Alimera Sciences Refinances Debt Facilit...	01/06/20
Alimera announced it has entered into a new US$45 million term loan agreement with investment affiliates managed by Solar Capital Partners. The post A...

Alimera Sciences Announces Board???s App...	11/07/19
Alimera Sciences, Inc. (ALIM) (???Alimera???), a leader in the commercialization and development of prescription ophthalmology treatments for the mana...

The Daily Biotech Pulse: Puma Leaps, Aer...	09/04/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 3) ...

The Daily Biotech Pulse: EC Nod For Bris...	08/28/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 27) ...

The Daily Biotech Pulse: Roche-Spark Dea...	07/31/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 30) ...

EyePoint: Evaluating The Prospects Of An...	05/13/19
No summary available.

Alimera Sciences, Inc. (ALIM) CEO Dan My...	05/03/19
Alimera Sciences, Inc. (NASDAQ:ALIM) Q1 2019 Earnings Conference Call April 30, 2019 09:00 AM ET Company Participants Scott Gordon - President of Core...

Alimera Sciences EPS in-line, beats on r...	04/29/19
No summary available.

Alimera's ILUVIEN approved in Kuwait	03/21/19
No summary available.

Alimera Sciences, Inc. (ALIM) CEO Dan My...	02/19/19
No summary available.

Alimera Sciences, Inc. 2018 Q4 - Results...	02/19/19
No summary available.

Alimera Sciences beats by $0.01, beats o...	02/18/19
No summary available.

Alimera Sciences affirms record Q4 and F...	01/07/19
No summary available.

Alimera Sciences affirms record Q4 and F...	01/07/19
No summary available.

ANALYST RATINGS

0 analyst ratings (Last 3 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	2021-02-24 (AMC)	Est. (EPS/Rev.)	($0.04)/ 13.43M
Actual (EPS/Rev.)	$-0.18/ $13.77 M	EPS (TTM)	0

TRADERS TRACKING $ALIM

No traders tracking are currently recommending this stock

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.